Invention Grant
US09138422B2 Method of using antimycin A to downregulate Wnt/b-catenin pathway to treat gefitinib resistant cancer
有权
使用抗霉素A下调Wnt / b-连环蛋白途径治疗吉非替尼耐药性癌症的方法
- Patent Title: Method of using antimycin A to downregulate Wnt/b-catenin pathway to treat gefitinib resistant cancer
- Patent Title (中): 使用抗霉素A下调Wnt / b-连环蛋白途径治疗吉非替尼耐药性癌症的方法
-
Application No.: US14058066Application Date: 2013-10-18
-
Publication No.: US09138422B2Publication Date: 2015-09-22
- Inventor: Chi-Ying F. Huang , Chi-Tai Yeh , Chun-Hung Wu , Yu-Wen Liu
- Applicant: Chi-Ying F. Huang , Chi-Tai Yeh , Chun-Hung Wu , Yu-Wen Liu
- Agency: WPAT, P.C.
- Agent Anthony King
- Main IPC: A61K31/365
- IPC: A61K31/365 ; A61K31/5377 ; A61K45/06 ; A61K31/517
Abstract:
The present invention provides a method for inhibiting the growth of cancer stem cells, particularly colorectal cancer stem cells, liver cancer stem cells, lung cancer stem cells or breast cancer stem cells, comprising administering to a subject in need thereof a therapeutically effective amount of a compound of antimycin A or a pharmaceutically acceptable salt thereof, together with a pharmaceutically acceptable carrier.
Public/Granted literature
- US20140045841A1 METHOD FOR INHIBITING THE GROWTH OF CANCER STEM CELL Public/Granted day:2014-02-13
Information query
